This article is for patients with gastroenteropancreatic neuroendocrine tumors (GEP-NETs) who are receiving or considering lutetium Lu-177 dotatate - also called PRRT (peptide receptor radionuclide therapy). Diarrhea and loose stools are already part of daily life for many NET patients, so it is natural to ask whether PRRT will make things worse. The short answer is: it depends on the cause. Some bowel changes during PRRT come from the treatment process itself. Others come from the tumor - and over time, PRRT may actually reduce them. Understanding the difference helps you and your care team plan ahead.
Why Your NET Already Causes Diarrhea
Many NETs - especially midgut tumors - release hormones such as serotonin, histamine, and bradykinin into the bloodstream. This is called carcinoid syndrome. One of its most common signs is watery diarrhea, sometimes five to ten times a day. The gut responds to these excess hormones by moving food through too quickly and absorbing too little fluid.
Somatostatin analogues (SSAs) - drugs like octreotide LAR and lanreotide - are usually the first treatment for carcinoid syndrome. According to the Neuroendocrine Tumor Research Foundation, SSAs provide partial or complete symptom relief for about half to two-thirds of patients with carcinoid syndrome diarrhea. But for some people, SSAs lose their effect over time, and symptoms return or worsen despite ongoing therapy.
This is when PRRT may become an option. If your tumor keeps causing diarrhea despite SSA therapy, and a Ga-68 DOTATATE PET scan confirms adequate somatostatin receptor expression, PRRT may be considered as the next step. To understand how that scan determines eligibility, see our guide on how Ga-68 DOTATATE PET determines your PRRT eligibility.
How Lu-177 DOTATATE Affects Your Gut
PRRT delivers targeted radiation to tumor cells that carry somatostatin receptors. As those cells are damaged, the tumor may release a surge of hormones before it begins to shrink. This can cause a short-term worsening of carcinoid symptoms such as diarrhea, flushing, and abdominal cramping in the days just after a cycle. This is sometimes called a tumor flare reaction.
Research on corticosteroid prophylaxis during Lu-177 DOTATATE treatment found that increased abdominal pain occurred in 22% of patients and small bowel obstruction occurred in 7% of patients during or after PRRT. These figures come from a population with advanced disease, and most cases resolved with supportive management. A separate analysis found that carcinoid crisis - a sudden, severe surge of carcinoid symptoms including diarrhea and flushing - occurs in roughly 1 to 2% of PRRT recipients, most often within 12 to 48 hours of the first dose. Your care team will be alert to these reactions, especially after cycle one.
Will PRRT Make Diarrhea Better or Worse Over Time?
This is the question most patients want answered first. The evidence suggests that once PRRT starts working on the tumor, diarrhea often improves.
The NETTER-1 trial, published in The New England Journal of Medicine, compared PRRT against high-dose octreotide in patients with midgut NETs. Patients in the PRRT group experienced around three fewer days of diarrhea per four-week period compared to those on high-dose octreotide alone. For someone whose day is organized around bathroom access, three fewer days of diarrhea each month is a real change in daily life.
A symptom diary study in midgut NET patients tracked bowel changes across four PRRT cycles. On average, daily bowel movement frequency fell from 6.1 per day before treatment to 4.6 per day after multiple cycles. These are group averages - your own response will depend on your tumor type, grade, and extent of disease.
The pattern: the short-term spike in bowel symptoms in the first one to two weeks after each cycle is the trade-off for longer-term improvement as the tumor shrinks and produces fewer hormones. To understand more about what PRRT may and may not control for carcinoid syndrome, see Will PRRT Control Your Carcinoid Syndrome Symptoms?
Why the Amino Acid Infusion Upsets Your Stomach
Many patients are surprised to learn that nausea and stomach upset on infusion day are often not caused by the Lu-177 dotatate itself. The main culprit is the amino acid infusion given alongside every cycle to protect your kidneys.
Before and during each PRRT cycle, you receive an intravenous drip of amino acids - typically lysine and arginine. These compete with the radioactive compound for reabsorption in the renal tubules, reducing the dose the kidneys receive. Without this infusion, Lu-177 dotatate would accumulate in the kidneys over a four-cycle course and could cause lasting damage. The amino acid solution runs over several hours, and this - not the Lu-177 itself - is what causes most of the nausea, vomiting, and loose stools that patients experience on treatment day.
Anti-nausea medicines (antiemetics) are given before and during the infusion to reduce this effect. Most centers use ondansetron or a similar drug, sometimes combined with a low-dose steroid. Even with these medicines, some patients still feel queasy for 12 to 24 hours after each cycle. This is expected and temporary - it usually eases once the amino acid drip is finished and the compound begins to clear from your system.
How to Manage Bowel Changes Across Each PRRT Cycle
There is no single approach that works for every NET patient. Here is what specialist NET teams typically recommend as part of supportive care. Always confirm any specific measures with your own oncologist or treatment center before following them.
- Continue your somatostatin analogue if prescribed. Most patients stay on octreotide LAR or lanreotide throughout PRRT. Your team will advise on timing - the SSA injection and the PRRT infusion are typically spaced a specific number of days apart. Do not adjust or stop your SSA without guidance from your oncologist.
- Stay hydrated on treatment days and the days after. Diarrhea removes fluid quickly. Aim for clear fluids - water, diluted juice, or broth - throughout the days around each cycle. If you cannot keep fluids down for more than a few hours, contact your care team. Severe dehydration may need intravenous fluids.
- Eat small, plain meals around your infusion. Rich, spicy, or high-fat foods can worsen loose stools. Plain rice, boiled chicken, bananas, and plain toast are often easier on the gut. Your treatment center may provide a dietary guide specific to PRRT.
- Ask your team before taking any anti-diarrhea medication. Loperamide is sometimes used for NET-related diarrhea, but it should only be taken on advice from your care team. For carcinoid syndrome diarrhea specifically, SSAs are usually the preferred approach. Your team will advise what is safe alongside your current treatment plan.
- Replenish what diarrhea takes out. Frequent loose stools deplete electrolytes - particularly sodium, potassium, and magnesium. Oral rehydration solutions help restore these. Some patients also benefit from nutritional support to maintain stable intake during treatment weeks. If you want over-the-counter options to help support micronutrient levels, you can look at vitamin and mineral options - though always discuss any new supplement with your care team before starting it.
Warning Signs That Need Your Care Team's Attention
You can manage most bowel changes during PRRT at home with rest, hydration, and plain food. But some situations need a prompt call to your team. Contact them if you notice any of the following:
- Diarrhea that does not settle within 48 hours of your infusion
- More than six to eight loose stools per day, or significantly more than your pre-treatment baseline
- Sudden or severe abdominal cramping or pain
- Signs of dehydration: dark urine, dizziness, dry mouth, or confusion
- Blood in your stool
- Fever above 38 degrees Celsius (100.4 degrees Fahrenheit), which may point to infection alongside bowel irritation
These symptoms can sometimes point to a more serious complication such as a tumor flare reaction affecting the small bowel, or early signs of carcinoid crisis. These events are not common, but reporting them quickly matters. Waiting to see how things develop can make a manageable situation harder to treat.
How Bowel Symptoms Factor Into Your Next Cycle
PRRT is typically given in four cycles, spaced around eight weeks apart. Before each cycle, your team checks blood results and your overall condition. Your team will assess ongoing or severe diarrhea, especially if it has caused weight loss or dehydration, before your next cycle. Your team may adjust the schedule, provide additional supportive treatment first, or investigate whether something else is contributing to your symptoms.
Tell your team if bowel changes are significantly affecting your daily life. Keeping you stable and comfortable across all four cycles is the goal, and that requires an honest account of how you are feeling between appointments.
If you are still deciding whether PRRT is right for you, or planning where to receive it, the first consultation is the right moment to raise concerns about your existing gut symptoms. Our article on your first PRRT consultation and eligibility screening explains what to bring and what that appointment typically covers.
A Note for Patients Travelling for Treatment
If you are coming from another country to receive PRRT in India or elsewhere, managing bowel changes during treatment needs some practical preparation before you travel. Carry oral rehydration sachets. Locate the nearest pharmacy to your accommodation before your first cycle. Travel with any anti-nausea and supportive medications already in your luggage. Ask your treatment center, in advance, who you can contact if symptoms become severe between cycles and how quickly they can respond. If you are weighing whether PRRT is the right step and want to think through how side effects like diarrhea would be managed as an international patient, the Art of Healing Cancer team offers teleconsultations before you commit to the journey.
When to Talk to Your Doctor
Speak with your oncologist or NET specialist before your first PRRT cycle if your carcinoid syndrome diarrhea has been worsening recently, if you have had unintentional weight loss, or if you are taking any over-the-counter supplements or herbal remedies. Speak with them promptly during treatment if you experience any of the warning signs listed above. If you are comparing PRRT against other options, ask directly how your existing bowel symptoms affect the decision - it is a fair and important question to bring to your care team.
This article is for general information and is not a substitute for medical advice. Always consult your oncologist or care team about your specific situation.
Frequently asked questions
Is diarrhea during Lu-177 DOTATATE PRRT normal?
Yes, some bowel changes are expected during PRRT. They can come from two sources: carcinoid syndrome caused by the tumor releasing hormones as it is damaged, and the amino acid infusion given during each cycle to protect your kidneys. Short-term loose stools or nausea in the 24 to 48 hours after each cycle are common. If diarrhea is severe or lasts more than two days, contact your care team.
Will PRRT make my carcinoid syndrome diarrhea permanently worse?
The evidence suggests the opposite is more likely over time. The NETTER-1 trial found that patients on PRRT experienced around three fewer days of diarrhea per four-week period compared to patients on high-dose octreotide alone. A symptom diary study also found that average daily bowel movement frequency fell from 6.1 to 4.6 per day across four cycles of PRRT. There may be a short-term worsening after each cycle as the tumor reacts, but the longer trend is typically improvement as the tumor shrinks.
How long does bowel upset last after each PRRT cycle?
Most patients find that nausea and loose stools settle within 48 to 72 hours of each cycle. The amino acid infusion - the main cause of nausea on treatment day - is finished within a few hours. Anti-nausea medication is given routinely to help manage the immediate post-infusion period. If symptoms persist beyond 48 hours or are severe, contact your care team.
Can I take loperamide for diarrhea during PRRT?
Ask your care team before taking any anti-diarrhea medication. Loperamide may be appropriate in some situations, but for carcinoid syndrome diarrhea, somatostatin analogues are usually the preferred approach since they target the hormonal cause of the problem. Your team will advise what is safe given your specific treatment plan and current medications.
What should I eat to reduce diarrhea during PRRT?
Plain, low-fiber, low-fat foods are generally easier on the gut around your infusion day. Rice, boiled chicken, bananas, and plain toast are often recommended. Spicy, rich, or heavily processed foods can worsen loose stools and are best avoided in the days around each cycle. Your treatment centre may provide a dietary guide specific to PRRT patients.
Should I stop my octreotide or lanreotide injection during PRRT?
Generally no. Most patients continue their somatostatin analogue throughout PRRT. The timing of the SSA injection relative to the PRRT infusion matters, and your team will give specific instructions. Stopping your SSA without guidance could cause a sudden worsening of carcinoid syndrome symptoms. Never adjust or stop your SSA without direction from your oncologist.
